Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “DENTAL AMALGAM”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 919 records · Page 51Linked to original sources
PubMed1977

In vitro corrosion of dental amalgams with different Cu content.

Both Cu amalgam and Sn-containing Ag amalgam alloys with Cu contents ranging from 2 to 30% were used in the investigation. The amalgams were placed in artificial saliva and the content of the dissolved Cu was determined after 1 month. The amalgam remained in the saliva for another 5 months. After the amalgams were removed from the solution, metallographic and microprobe examinations were made. The Cu amalgam released about 10 times more Cu to the artificial saliva than any of the other amalgams. The dispersion type amalgams showed a relatively large dissolution of Cu, while a smaller release was found from amalgam made of powder with one composition. The phases that appeared to be corroded first were gamma2 and Cu-Sn phases. In dispersion type amalgams the gamma phase appeared to be attacked. Most of the corrosion products remained inside the amalgam and were identified to be tin oxide chlorides.

Copper↗
PubMed1983

Corrosion of zinc-containing dental amalgam.

The gamma 1 lattice constant of amalgams with and without zinc kept under corrosive and non-corrosive conditions was determined at different times after trituration. Zinc disappeared during 1 d from the gamma 1 phase of an amalgam made from 0.9% Zn alloy and during 30 d from an amalgam made from 4% Zn alloy, when powdered amalgam was in contact with a 1% NaCl solution.

Corrosion↗
PubMed1996

Mercury vapor release from dental amalgam in patients with symptoms allegedly caused by amalgam fillings.

The aim of this study was to determine whether a group of patients with symptoms, self-related to their amalgam restorations, experienced an exposure to mercury vapor from their amalgam restorations that reached the range at which subtle symptoms have been reported in the literature. Furthermore, the aim was to determine whether the mercury exposure for these patients was significantly higher than for controls with no reported health complaints. The symptom group consisted of 10 consecutively selected patients from a larger group, referred by their physicians for investigation into any correlation between subjective symptoms and amalgam restorations. The control group consisted of 8 persons with no reported health complaints. The intra-oral release of mercury vapor was measured between 7:45 a.m. and 9:00 p.m. at intervals of 30-45 min, following a standardized schedule. The mercury levels in plasma, erythrocytes, and urine were also determined. The calculated daily uptake of inhaled mercury vapor, released from the amalgam restorations, was less than 5% of the daily uptake calculated at the lower concentration range given by the WHO (1991), at which subtle symptoms have been found in particularly sensitive individuals. The symptom group had neither a higher estimated daily uptake of inhaled mercury vapor, nor a higher mercury concentration in blood and urine than in the control group. The study provides no scientific support for the belief that the symptoms of the patients examined originated from an enhanced mercury release from their amalgam restorations.

Adult↗